USO 21550
Isang Phase II multi-center, open-label, single-arm dose escalation study ng Asciminib monotherapy sa 2nd Line Chronic Phase - Chronic Myelogenous Leukemia (ASC2ESCALATE)(CABL001AUS08)
Mga Uri ng Sakit: Lymphoma at Hematologic
Available sa:
- Norfolk (Brock Cancer Center)
- Newport News (Port Warwick III)
- Virginia Beach ( Princess Anne )
- Hampton (CarePlex)
- Chesapeake